article = {CRSS-2021-2-101}
title = {Treatment of Deep Vein Thrombosis Using Factor Xa Inhibitor Concurrent with Platinum Based Chemotherapy Regimen: A Case Report}
journal = {Case Reports and Series in Surgery}
year = {2021}
issn = {2733-2241}
doi = {http://dx.doi.org/10.31487/j.CRSS.2021.02.01}
url = {https://www.sciencerepository.org/treatment-of-deep-vein_CRSS-2021-2-101 
author = {Wan Mohd Akmal Bin Wan Sabri,Gobi Hariyanayagam Gunasekaran,Mohd Ezrul Helmi Bin Jamaluddin,}
keywords = { Deep vein thrombosis, novel oral anticoagulants, chemotherapy}
abstract ={Deep Vein Thrombosis (DVT) is a common treatment-related complication following surgery and chemotherapy. We are reporting a case of colorectal cancer-associated thrombosis during platinum-based chemotherapy. The patient was treated with Rivaroxaban (Xarelto), a highly selective direct Factor Xa inhibitor. This case report highlights the concurrent use of novel oral anticoagulants, which does not interrupt the chemotherapy schedule among patients receiving cytotoxic agents.}